Waldemar Sawicki, MD, PhD

Department of Internal Medicine and Hematology, Military Institute of Medicine-National Research Institute, Poland

Poster(s):

• 1406 - Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL – real-life data analysis of the Polish Adult Leukemia Group